Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-24

Clinical Trial Update: Rilonacept in Diabetes Mellitus Type 1: Safety Study [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 safety study of rilonacept in individuals with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rilonacept (rilonacept)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED